The Discovery of the Pathophysiological Aspects of Atherosclerosis — A Review

References

• Ruffer M. A. On arterial lesions found in Hgyptia mummies. J Path Bad, 1911, 15 : 453-465.
   Google Scholar
• Graul E. H. Environtologie - Fakten und Spekulationen. Medicef, 1985, 1 : 1-24.
   Google Scholar
• Kohn H. Zur Geschichte der Angina pectoris. Zschr klin Med, 1927, 106.
   Google Scholar
• Vesal A. De humani corporis fabrica. 1543, Basel.
   Google Scholar
• Fallopius G. Lectiones de partibus simularibus humani corporis. 1575, Padua.
   Google Scholar
• Harvey W. Exercitatio anatomica de motu cordis et sanguinis animalibus, 1628, London.
   Google Scholar
• Morgagni G. B. De sedibus et causis morborum. 1761, Venice.
   Google Scholar
• Von Haller A. Bibliotheca anatomica, Vol. II, 1774, Zurich.
   Google Scholar
• Heberden W. Some account to a disorder of the breast. Medical Transactions, Vol. II, London Read at the College, July 21st 1768.
   Google Scholar
• Jenner E. Letter on the relationship of coronary artery disease to angina pectoris. 1799 (cited in Kohn 1927).
   Google Scholar
• Parry C. H. In inquiry into the symptoms and causes of the syncope anginosa, commonly called angina pectoris. London 1799 (cited in Kohn 1927).
   Google Scholar
• Potain A. Des differentes formes de l’angine de poitrine. Gaz de’Hop 1880, p. 96 (cited in Kohn 1927).
   Google Scholar
• Lobstein J. F. Lehrbuch der pathologischen Anatomie. Vol. II, 1835, Brodhag’sche Buchhandlung Stuttgart.
   Google Scholar
• Rokitansky C. Über einige der wichtigsten Krankheiten der Arterien. 1852, K.u.K. hof- und Staatsdruckereinen, Wien.
   Google Scholar
• Virchow R. Über parenchymatöse Entzündung. Virclwws Arehiv PathAnat, 1852,4: 261-276.
   Google Scholar
• Saltykow S. Atherosklerose bei Kaninchen nach wiederholter Staphylokokkeninjektion. In : Aschoff L, Marchand F. (eds.) Beitrage Pathologische Anatomie. 43rd Edition, Jena, Fischer 1908, p. 147-176.
   Google Scholar
• STUCKEY. Über die Veränderungen der Kaninchenaorta unter dem Einflusse einer reichlichen animalischen Futterung. Inaugural-Dissertation, St. Petersburg, 1910.
   Google Scholar
• Anitschkow N. Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beilr Pathol Anat, 1913, 56 : 379-404.
   Google Scholar
• Finking G., Hanke H. Nikolaj Nikolalajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 1997, 135 : 1-7.
   PubMed Web of Science ®Google Scholar
• Ludden J. B., Bruger M, Wright I. S. Experimental atherosclerosis. IV. Effect of testosterone propionate and estradiol dipropionate on experimental atherosclerosis in rabbits. Arch Path, 1942, 33 : 58-62.
   Google Scholar
• Ross R., Glomset J. A. The pathogenesis of atherosclerosis (part I). NEJM, 1976, 295 : 369-377.
   PubMed Web of Science ®Google Scholar
• Ross R., Glomset J. A. The pathogenesis of atherosclerosis (part 1). NEJM, 1976, 295 : 420-425.
   PubMed Web of Science ®Google Scholar
• Bostom A. G., Selhub J. Homocysteine and arteriosclerosis. Circulation, 1999, 99 : 2361-2363.
   PubMed Web of Science ®Google Scholar
• Gupta S. Chronic infection in the aetiology of atherosclerosis - focus on Chlamydia pneumoniae. Atherosclerosis, 1999, 143 : 1-6.
   PubMed Web of Science ®Google Scholar
• Koenig W., Sund M., Frohlich M., Fischer H. G., Lowel H, Doring A., Hutchinson W. L., Pepys M. B. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men : results from the MONICA (Monitoring Trends ans Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992). Circulation, 1999, 99 : 237-242.
   PubMed Web of Science ®Google Scholar
• Brown M. S., Goldstein J. L. A receptor-mediated pathway for cholesterol homeostasis. Science, 1986, 232 : 34-47.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis : a perspective for the 1990s. Nature, 1993, 362 : 801-809.
   PubMed Web of Science ®Google Scholar
• Stary H. C. Composition and classification of human atheroscle-rosic lesions. Virchows Arch A Pathol Anat, 1992, 421 : 277-290.
   Google Scholar
• Fuster V., Badimon L., Badimon J. J., Cheesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. NEJM, 1992, 326 : 242-250.
   PubMed Web of Science ®Google Scholar
• Giroud D, Li J. M., Urban P, Meier B, Rutishauser W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography. Am J Cardiol, 1992, 69 : 729-732.
   PubMed Web of Science ®Google Scholar
• Hanke H., HÖHer M. Stellenwert der Cholesterinsenkung in der Sekundärprävention der koronaren Herzerkrankung. Med Welt, 1999, 50 : 153-159.
   Google Scholar
• Golledge J., Greenhalgh R. M., Davies A. H. The symptomatic carotid plaque. Stroke, 2000, 31: 774-781.
   PubMed Web of Science ®Google Scholar
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344 : 1383-1389.
   PubMed Web of Science ®Google Scholar
• Shepard J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., Macfarlane P. W., Mckillop J. H., Packard C. J. for the West of Scotland Coronary Prevention Study Group : Prevention of coronary heart diseasewith pravastatin in men with hypercholesterolemia. N Eng J Med, 1995, 333 : 1301-1307.
   PubMed Web of Science ®Google Scholar
• Sacks F. M., Pfeffer M. A., Move L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M. O., Wun C. C., Davies B. R., Braunwald E. for the Cholesterol and Recurrent Events Trial Investigators : The effect of pravastatin in coronary events after myocardial infarction in patients with average cholesterol levels. N Eng J Med, 1996,335 : 1001-1009.
   PubMed Web of Science ®Google Scholar
• Lipid Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med, 1998, 339 : 1349-1357.
   PubMed Web of Science ®Google Scholar
• Stamler J., Wentworth D., Neaton J. D. for the MRFIT Research Group : Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous or graded? Findings in 356 222 primary screenes of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA, 1986, 256 : 2823-2838.
   PubMed Web of Science ®Google Scholar
• Ornish D., Brown S. E., Scherwitz L. W., Billings J. H., Armstrong W. T., Ports T. A., Mclanahan S. M., Kirkeide R. L., Brand R. J., Gould K. L. Can lifestyle changes reverse coronary heart disease? Lancet, 1990, 336 : 129-133.
   PubMed Web of Science ®Google Scholar
• Brown B. G., Zhao X.-Q., Sacco D. E., Albers J. J. Lipid lowering and plaque regression - new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation, 1993, 87 : 1781-1791.
   PubMed Web of Science ®Google Scholar
• Deutsche Gesellschaft fur Kardiologie : Leitlinie: Koronare Herzkrankheit/Angina pectoris. Z Kardiol, 1998, 87 : 907-911.
   Google Scholar
• Wood D., De Backer G., Faergrman O., Graham I., Mancia G., PyÖrÄlÄ K. together with members of the Task Fores : Prevention of coronary heart disease in clinical practice. Eur Heart J, 1994, 15: 1300-1331.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis : An update. N Eng J Med, 1986, 314 : 488-500.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med, 1999, 340: 115-126.
   PubMed Web of Science ®Google Scholar